A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : BRAF

Search Conditions:
Search Keyword : BRAF
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: BRAF
Appearance Frequency: 163 time(s)
Long forms: 23

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
B-Raf proto-oncogene, serine/threonine kinase
(68 times)
Neoplasms
(35 times)
KRAS (20 times)
CRC (12 times)
EGFR (9 times)
2012 Human papillomavirus and gene mutations in head and neck squamous carcinomas.
B-Raf proto-oncogene
(27 times)
Neoplasms
(10 times)
MAPK (6 times)
EGFR (5 times)
MEK (4 times)
2014 BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis.
B-type Raf kinase
(27 times)
Medicine
(7 times)
PTC (14 times)
IHC (3 times)
mCRC (3 times)
2004 BRAF T1796A transversion mutation in various thyroid neoplasms.
B-rapidly accelerated fibrosarcoma
(11 times)
Neoplasms
(3 times)
KRAS (4 times)
MEK (3 times)
CRC (2 times)
2012 Gastrointestinal stromal tumors.
BRAF-wt
(6 times)
Endocrinology
(2 times)
CI (2 times)
ORR (2 times)
OS (2 times)
2007 BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism.
B-type Raf
(5 times)
General Surgery
(4 times)
PTC (4 times)
DLI (1 time)
FNA (1 time)
2005 High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes.
B-rapidly accelerated fibrosarcoma gene
(2 times)
Cell Communication
(1 time)
PI3K (2 times)
DUSP6 (1 time)
ERK (1 time)
2015 Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis.
BRAF wildtype
(2 times)
Neoplasms
(1 time)
CRC (1 time)
KRAS (1 time)
MAPK (1 time)
2016 The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells.
B-isoform of the Raf kinase
(1 time)
General Surgery
(1 time)
PTC (1 time)
2010 BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer.
10  B-raf gene
(1 time)
Drug Therapy
(1 time)
--- 2012 Vemurafenib: the road to personalized medicine in melanoma.
11  B-raf oncogene
(1 time)
Neoplasms
(1 time)
--- 2004 Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas.
12  B-Raf proto-oncogene, Ser/Thr kinase
(1 time)
Biochemistry
(1 time)
CRAF (1 time)
MAPK (1 time)
2020 Analyses of the oncogenic BRAFD594G variant reveal a kinase-independent function of BRAF in activating MAPK signaling.
13  B-raf serine/threonine kinase proto-oncogene
(1 time)
Neoplasms
(1 time)
CRC (1 time)
KRAS (1 time)
2017 KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population.
14  baroreflex arc function
(1 time)
Endocrinology
(1 time)
DCVAN (1 time)
1987 Computerized simultaneous determination of natural age groups for 32 baroreflex arc function parameters and of the corresponding normal ranges for use in the diagnosis of cardiovascular autonomic neuropathy.
15  binimetinib, with a v-Raf murine sarcoma viral oncogene homolog B
(1 time)
Neoplasms
(1 time)
MEK (1 time)
MEKAR (1 time)
OCT (1 time)
2016 MEK inhibitor-associated retinopathy(MEKAR) in metastatic melanoma: Long-term ophthalmic effects.
16  bismuth potassium citrate, rabeprazole, amoxicillin, and furazolidone
(1 time)
Gastroenterology
(1 time)
BRAC (1 time)
2015 Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
17  BRAF and PTEN loss, with the MAPK
(1 time)
Chemistry
(1 time)
MAPK (1 time)
PCA (1 time)
WT (1 time)
2014 In vitro treatment of melanoma brain metastasis by simultaneously targeting the MAPK and PI3K signaling pathways.
18  BRAF gene
(1 time)
Neurology
(1 time)
--- 2019 BRAF V600E-mutated central nervous system tumor with divergent morphological feature - Anaplastic pleomorphic xanthoastrocytoma-like and astroblastoma-like.
19  BRAF inhibitors
(1 time)
Molecular Biology
(1 time)
CRC (1 time)
OSmet (1 time)
2017 Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights.
20  BRAF mutated
(1 time)
Neoplasms
(1 time)
MAPK (1 time)
2016 The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells.
21  BRAF mutation analysis
(1 time)
Neoplasms
(1 time)
DOR (1 time)
FNA (1 time)
GAL-3-ICC (1 time)
2017 Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology.
22  Business Recovery Assessment Framework
(1 time)
Disaster Medicine
(1 time)
--- 2018 Business recovery: an assessment framework.
23  B‑Raf
(1 time)
Neoplasms
(1 time)
CDK (1 time)
HDAC (1 time)
2020 Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition.